According to Evolent Health's latest financial reports the company's current earnings (TTM) are -$0.15 B. In 2022 the company made an earning of -$46.51 M a decrease over its 2021 earnings that were of -$4.38 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.15 B | 218.68% |
2022 | -$46.51 M | 962.73% |
2021 | -$4.38 M | -98.57% |
2020 | -$0.31 B | -1.93% |
2019 | -$0.32 B | 542.29% |
2018 | -$48.67 M | -33.12% |
2017 | -$72.77 M | -69.57% |
2016 | -$0.24 B | 456.55% |
2015 | -$42.98 M | 269.05% |
2014 | -$11.65 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
National Healthcare
NHC | $89.06 M | -160.10% | ๐บ๐ธ USA |
Global Cord Blood CORBF | $94.91 M | -164.05% | ๐ญ๐ฐ Hong Kong |
Graham Holdings GHC | $0.36 B | -344.47% | ๐บ๐ธ USA |
CryoLife CRY | $2.06 M | -101.39% | ๐บ๐ธ USA |